Clover Health is trading at $4.49, down 4.17%, amid a broader market sell-off.
- On October 16, the supplied market context reported declines in the S&P 500, Nasdaq and Dow.
- Available coverage surfaced no clear company-specific catalyst. Proposed officer share sales were described as non-discretionary sell-to-cover transactions for RSU tax withholding; this does not establish them as the cause of the decline.